RELATED PRODUCTS Femtosecond Workstation

FEMTO-CATARACT

Some of the products and/or specific features as well as the procedures featured on this website may not be approved in your country and thus may not be available there. The VICTUS platform has CE Marking for capsulotomy, lens fragmentation, arcuate corneal incisions, corneal incisions, LASIK flap, INTRACOR®, penetrating keratoplasty and intrastromal channel incisions for intracorneal ring segments. Indications may vary by country. In the United States, the VICTUS Femtosecond Laser Platform is indicated for use in the creation of a corneal flap in patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea; for anterior capsulotomy during cataract surgery; and for the creation of cuts / incisions in the cornea in patients undergoing cataract surgery or other ophthalmic treatment requiring cuts/incisions in the cornea and for laser assisted fragmentation during cataract surgery for nuclear cataracts, not for fragmentation of posterior subcapsular and cortical cataracts.

Introducing the VICTUS™ Femtosecond Laser Platform

The VICTUS™ Femtosecond Laser Platform is the first and only femtosecond laser single platform for cataract, refractive and therapeutic procedures providing unparalleled versatility and leading-edge technology.*

The VICTUS Platform can perform the key steps in the
cataract surgery procedure
:
  • Anterior capsulotomy
  • Lens fragmentation
  • Arcuate Incisions
  • Corneal incisions

The VICTUS Femtosecond Laser Platform offers advanced engineering and unique features such as:

Real-time, high-contrast OCT
Enables Image-guided cataract surgery and planning for a more precise procedure



Curved Patient Interface
  • Controlled by Intelligent Pressure Sensors
  • Docking is controlled and optimized
  • Three-dimensional eye force/pressure evaluation
  • Designed to reduce applanation of the cornea and minimize corneal deformation and folds
  • Maintains consistent suction at all times



Precision performance

Anterior capsulotomy vs manual1
  • Significantly improves accuracy and predictability of circularity and centration
Precise control of diameter1

Phaco power optimization1
  • Multiple fragmentation options for grades to 5
  • Demonstrated reduction of EPT

Faster pulse rates up to 160 kHz
  • Help minimize treatment time
  • Enhance control


1.Data courtesy of K. P. Reddy, MD, Hyderabad, India.

* The VICTUS platform has CE Marking for capsulotomy, lens fragmentation, arcuate corneal incisions, corneal incisions, LASIK flap, INTRACOR®, penetrating keratoplasty and intrastromal channel incisions for intracorneal ring segments. Indications may vary by country. In the United States, the VICTUS Femtosecond Laser Platform is indicated for use in the creation of a corneal flap in patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea; for anterior capsulotomy during cataract surgery; and for the creation of cuts / incisions in the cornea in patients undergoing cataract surgery or other ophthalmic treatment requiring cuts/incisions in the cornea and for laser assisted fragmentation during cataract surgery for nuclear cataracts, not for fragmentation of posterior subcapsular and cortical cataracts.










Animation of VICTUS lens fragmentation patterns (Copyright© 2012, Mike P. Holzer, MD, Heidelberg, Germany)


Capsulotomy and lens fragmentation with radial cuts


Free floating capsulotomy flap


Capsulotomy and lens fragmentation with radial and quadrant cuts


Some of the products and/or specific features as well as the procedures featured on this website may not be approved in your country, including Canada, and thus may not be available there. The VICTUS platform has CE Marking for capsulotomy, lens fragmentation, arcuate corneal incisions, corneal incisions, LASIK flap, INTRACOR®, penetrating keratoplasty and intrastromal channel incisions for intracorneal ring segments. Indications may vary by country. In the United States, the VICTUS Femtosecond Laser Platform is indicated for use in the creation of a corneal flap in patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea; for anterior capsulotomy during cataract surgery; and for the creation of cuts / incisions in the cornea in patients undergoing cataract surgery or other ophthalmic treatment requiring cuts/incisions in the cornea and for laser assisted fragmentation during cataract surgery for nuclear cataracts, not for fragmentation of posterior subcapsular and cortical cataracts. The TECHNOLAS TENEO 317 is CE marked but NOT approved for use in the US. The TECHNOLAS TENEO 317 is not approved in all countries.
SUPRACOR excimer laser treatment and INTRACOR are CE marked but NOT approved for use in the US. SUPRACOR excimer laser treatment and INTRACOR and are not approved in all countries. Please contact our regional representative regarding individual availability in your respective market.
CAREERS | IMPRINT & LEGAL STATEMENTS

© 2012-2014 TECHNOLAS Perfect Vision GmbH. All Rights Reserved
A Bausch + Lomb Company
powered by DASAT
TW-02/190214